PFIZER - Technical Analysis with Chart Patterns & Indicators
← Back to ListKey Parameters
⭐ Technical Rating: 3.8
✅ Positive
Pfizer demonstrates consistent profitability with a rising PAT over the last two quarters and maintains a respectable ROCE of 24.1%. The company has also recently declared a dividend, signaling confidence in its financial health.
⚠️ Limitation
Despite strong earnings growth, the stock’s valuation is elevated relative to its industry peers (P/E ratio of 28.7) and a high PEG ratio of 3.55 suggests overvaluation. Furthermore, FII holdings have decreased, which could indicate waning international investor interest.
📉 Company Negative News
Recent news indicates that while Pfizer achieved strong profit growth, market analysts are concerned about the stock’s valuation, suggesting potential downside risk. The declaration of a ₹75 dividend per share does not significantly alter these concerns related to overvaluation.
📈 Company Positive News
None found.
🏭 Industry
The pharmaceutical industry is currently experiencing moderate growth driven by an aging global population and ongoing research into novel therapies. Companies with established brands and strong R&D pipelines, like Pfizer, tend to perform well, although valuations can be sensitive to drug development risks.
🧾 Conclusion
Based on the current chart patterns, the stock exhibits a slight upward trend, supported by rising RSI levels above 60 (indicating positive momentum). An optimal entry zone could be between ₹4,750 – ₹4,800, utilizing the recent support level around ₹4,825. A potential exit zone would be established at the resistance level of ₹5,100 , offering a reasonable target profit. Overall, while cautiously optimistic given the momentum, investors should monitor for signs of overextension or reversal patterns.